Skip to main content
Premium Trial:

Request an Annual Quote

William Hagstrom

William Hagstrom has joined the board of CareDx. Hagstrom is the founder and CEO of Octave Bioscience, an early stage molecular diagnostics firm that is focused on neurodegenerative diseases. Before that, he was president and CEO of Crescendo Bioscience, now part of Myriad Genetics. He also has served as president of Alpha BioPartners, interim CEO of Selexys Pharmaceuticals and Inoveon, and chairman and CEO of UroCor.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.